Haplotype analysis of the NADPH oxidase p22 gene in patients with bronchial asthma

International Archives of Allergy and Immunology

Volumn 148, Issue 1, 2008, Pages 73-80

  Izakovicova Holla, Lydie ^a   Kaňková, Kateřina ^a   Znojil, Vladimir ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Asthma; CYBA gene; Haplotype analysis; NADPH oxidase; p22phox; Single nucleotide polymorphism

Indexed keywords

ALLERGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P22PHOX; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLASSIFICATION ALGORITHM; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRICK TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLERGENS; ASTHMA; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN TESTS;

EID: 49849086386     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151508     Document Type: Article

References (36)

1. Rahman I, Biswas SK, Kode A: Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006;533:222-239.
2. Nagata M: Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy 2005;4:503-504.
3. Kinnula VL, Crapo JD, Raivio KO: Biology of disease: generation and disposal of reactive oxygen metabolites in the lung. Lab Incest 1995;73:3-19.
4. Kinnula VL, Chang L, Everitt JI, Crapo JD: Oxidants and antioxidants in alveolar epithelial type II cells: in situ, freshly isolated, and cultured cells. Am J Physiol 1992;262:L69-L77.
5. Kinnula VL: Production and degradation of oxygen metabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 2005;4:465-470.
6. Mak JC, Chan-Yeung MM: Reactive oxidant species in asthma. Curr Opin Pulm Med 2006;12:7-11.
7. Misso NL, Thompson PJ: Oxidative stress and antioxidant deficiencies in asthma: potential modification by diet. Redox Rep 2005;10:247-255.
8. Vural H, Aksoy N, Ceylon E, Gencer M, Ozquner F: Leukocyte oxidant and antioxidant status in asthmatic patients. Arch Med Res 2005;36:502-506.
9. Mak JC, Leung HC, Ho SP, Law BK, Lam WK, Tsang KW, Ip MS, Chan-Yeung M: Systemic oxidative and antioxidative status in Chinese patients with asthma. J Allergy Clin Immunol 2004;114:260-264.
10. Kirkham P, Rahman I: Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 2006;111:476-494.
11. Griendling KK, Sorescu D, Ushio-Fukai M: NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
12. Ushio-Fukai M, Zarafi AM, Fukui T, Ishizaka N, Griendling KK: p22 phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996;271:23317-23321.
13. phox gene: identification of a new polymorphism associated with hypertension. FEBS Lett 2003;542:27-31.
14. phox): gene structure, chromosomal localization and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990;86:1729-1737.
15. Wyche KE, Wang SS, Griendling KK, Dikalov SI, Austin H, Rao S, Fink B, Harrison DG, Zafari AM: C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 2004;43:1246-1251.
16. Rae J, Noack D, Heyworth PG, Ellis BA, Curnutte JT, Gross AR: Molecular analysis of 9 new families with chronic granulomatous disease caused by mutations in CYBA, the gene encoding p22 phox . Blood 2000;96:1106-1112.
17. Global strategy for asthma management and prevention: global initiative for asthma. National Institute of Health, Publication 01-3659. NHLBI/WHO, 2002.
18. Bousquet J, Van Cauwenberge PN, Khaltaev N: Allergic rhinitis and its impact on asthma: ARIA workshop report. J Allergy Clin Immunol 2001;108:S148-S333.
19. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92:44-47.
20. Buckova D, Holla LI, Vasku A, Znojil V, Vacha J: Lack of association between atopic asthma and the tumor necrosis factor alpha-308 gene polymorphism in a Czech population. J Invest Allergol Clin Immunol 2002;12:192-197.
21. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M: Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998;97:135-137.
22. Holla LI, Fassmann A, Benes P, Halabala T, Znojil V: 5 polymorphisms in the transforming growth factor-beta 1 gene (TGF-beta 1) in adult periodontitis. J Clin Periodontol 2002;29:336-341.
23. MacNee W: Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195-207.
24. Lee PL, West C, Crain K, Wang L: Genetic polymorphisms and susceptibility to lung disease. J Negat Results Biomed 2006;11:5:5.
25. phox C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 2004;175:109-115.
26. phox gene on vascular superoxide production in atherosclerosis. Circulation 2000;102:1744-1747.
27. phox C242T polymorphism and ischemic stroke in Japan: the Fukuoka Stroke Registry and the Hisayama study. Eur J Neurol 2007;14:1091-1097.
28. + channel. Evidence that gp91-phox functions as an essential part of the channel. J Biol Chem 1995;270: 5905-5916.
29. Macías-Reyes A, Rodríguez-Esparragón F, Caballero-Hidalgo A, Hernández-Trujillo Y, Medina A, Rodríguez- Pérez JC: Insight into the role of CYBA A640G and C242T gene variants and coronary heart disease risk. A case-control study. Free Radic Res 2008;42:82-92.
30. Mak JC, Leung HC, Ho SP, Ko FW, Cheung AH, Ip MS, Chan-Yeung MM: Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy 2006;36:440-447.
31. Batra J, Pratap Singh T, Mabalirajan U, Sinha A, Prasad R, Ghosh B: Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. Thorax 2007;62:16-22.
32. Holla LI, Stejskalova A, Znojil V, Vasku A: Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases. Clin Exp Allergy 2006;36:1592-1601.
33. Holla LI, Stejskalova A, Znojil V, Vasku A: Association study of promoter polymorphisms within the NOS3 gene and allergic disease. Int Arch Allergy Immunol 2006;141:103-109.
34. Leung TF, Liu EK, Tang NL, Ko FW, Li CY, Lam CW, Wong GW: Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children. Clin Exp Allergy 2005;35:1288-1294.
35. Riccioni G, D'Orazio N: The role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: adjuvant therapy or not? Expert Opin Investig Drugs 2005;14:1145-1155.
36. Pearson PJ, Lewis SA, Britton J, Fogarty A: Vitamin E supplements in asthma: a parallel group randomized placebo controlled trial. Thorax 2004;59:652-656.